1887

Abstract

Epstein–Barr virus (EBV) latent membrane protein 2A (LMP2A) blocks B-cell receptor (BCR) signalling after BCR cross-linking to inhibit activation of lytic EBV, and ectopically expressed LMP2B negatively regulates LMP2A. Here, it is demonstrated that silencing of in EBV-harbouring Burkitt's lymphoma Akata cells results in reduced expression of EBV immediate-early lytic gene mRNA and late lytic gp350/220 protein upon BCR cross-linking. Similarly, reduction of lytic EBV activation was observed in Akata cells overexpressing LMP2A. In contrast, silencing of expression resulted in higher lytic EBV mRNA and protein expression in BCR cross-linked Akata cells. These observations indicate a role for LMP2B distinct from that of LMP2A in regulation of lytic EBV activation in the host cell and support the hypothesis that LMP2B exhibits a negative-regulatory effect on the ability of LMP2A to maintain EBV latency by preventing the switch to lytic replication.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82790-0
2007-05-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/5/1454.html?itemId=/content/journal/jgv/10.1099/vir.0.82790-0&mimeType=html&fmt=ahah

References

  1. Allen, M. D., Young, L. S. & Dawson, C. W. ( 2005; ). The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J Virol 79, 1789–1802.[CrossRef]
    [Google Scholar]
  2. Babcock, G. J. & Thorley-Lawson, D. A. ( 2000; ). Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci U S A 97, 12250–12255.[CrossRef]
    [Google Scholar]
  3. Babcock, G. J., Hochberg, D. & Thorley-Lawson, A. D. ( 2000; ). The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13, 497–506.[CrossRef]
    [Google Scholar]
  4. Bernasconi, M., Berger, C., Sigrist, J. A., Bonanomi, A., Sobek, J., Niggli, F. K. & Nadal, D. ( 2006; ). Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virol J 3, 43 [CrossRef]
    [Google Scholar]
  5. Caldwell, R. G., Brown, R. C. & Longnecker, R. ( 2000; ). Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J Virol 74, 1101–1113.[CrossRef]
    [Google Scholar]
  6. Daibata, M., Humphreys, R. E., Takada, K. & Sairenji, T. ( 1990; ). Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata. J Immunol 144, 4788–4793.
    [Google Scholar]
  7. Fruehling, S. & Longnecker, R. ( 1997; ). The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241–251.[CrossRef]
    [Google Scholar]
  8. Fruehling, S., Lee, S. K., Herrold, R., Frech, B., Laux, G., Kremmer, E., Grasser, F. A. & Longnecker, R. ( 1996; ). Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J Virol 70, 6216–6226.
    [Google Scholar]
  9. Fukuda, M. & Longnecker, R. ( 2005; ). Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation. J Virol 79, 8655–8660.[CrossRef]
    [Google Scholar]
  10. Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. ( 1977; ). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36, 59–74.[CrossRef]
    [Google Scholar]
  11. Konishi, K., Maruo, S., Kato, H. & Takada, K. ( 2001; ). Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. J Gen Virol 82, 1451–1456.
    [Google Scholar]
  12. Longnecker, R., Druker, B., Roberts, T. M. & Kieff, E. ( 1991; ). An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J Virol 65, 3681–3692.
    [Google Scholar]
  13. Longnecker, R., Miller, C. L., Miao, X. Q., Marchini, A. & Kieff, E. ( 1992; ). The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J Virol 66, 6461–6469.
    [Google Scholar]
  14. Lynch, D. T., Zimmerman, J. S. & Rowe, D. T. ( 2002; ). Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells. J Gen Virol 83, 1025–1035.
    [Google Scholar]
  15. Mancao, C., Altmann, M., Jungnickel, B. & Hammerschmidt, W. ( 2005; ). Rescue of ‘crippled’ germinal center B cells from apoptosis by Epstein-Barr virus. Blood 106, 4339–4344.[CrossRef]
    [Google Scholar]
  16. Matskova, L., Ernberg, I., Pawson, T. & Winberg, G. ( 2001; ). C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal. J Virol 75, 10941–10949.[CrossRef]
    [Google Scholar]
  17. Merchant, M., Caldwell, R. G. & Longnecker, R. ( 2000; ). The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol 74, 9115–9124.[CrossRef]
    [Google Scholar]
  18. Miller, C. L., Lee, J. H., Kieff, E., Burkhardt, A. L., Bolen, J. B. & Longnecker, R. ( 1994a; ). Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction. Infect Agents Dis 3, 128–136.
    [Google Scholar]
  19. Miller, C. L., Lee, J. H., Kieff, E. & Longnecker, R. ( 1994b; ). An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A 91, 772–776.[CrossRef]
    [Google Scholar]
  20. Miller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B. & Kieff, E. ( 1995; ). Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155–166.[CrossRef]
    [Google Scholar]
  21. Murray, P. G. & Young, L. S. ( 2002; ). The role of the Epstein-Barr virus in human disease. Front Biosci 7, d519–d540.[CrossRef]
    [Google Scholar]
  22. Portis, T., Cooper, L., Dennis, P. & Longnecker, R. ( 2002; ). The LMP2A signalosome – a therapeutic target for Epstein-Barr virus latency and associated disease. Front Biosci 7, d414–d426.[CrossRef]
    [Google Scholar]
  23. Portis, T., Ikeda, M. & Longnecker, R. ( 2004; ). Epstein-Barr virus LMP2A: regulating cellular ubiquitination processes for maintenance of viral latency?. Trends Immunol 25, 422–426.[CrossRef]
    [Google Scholar]
  24. Rickinson, A. B. & Kieff, E. ( 2001; ). Epstein-Barr Virus. In Fields Virology, 4th edn, pp. 2575–2627. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
  25. Rovedo, M. & Longnecker, R. ( 2007; ). Epstein Barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity. J Virol 81, 84–94.[CrossRef]
    [Google Scholar]
  26. Rowe, D. T. ( 1999; ). Epstein-Barr virus immortalization and latency. Front Biosci 4, D346–D371.[CrossRef]
    [Google Scholar]
  27. Sample, J., Liebowitz, D. & Kieff, E. ( 1989; ). Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol 63, 933–937.
    [Google Scholar]
  28. Schaefer, B. C., Mitchell, T. C., Kappler, J. W. & Marrack, P. ( 2001; ). A novel family of retroviral vectors for the rapid production of complex stable cell lines. Anal Biochem 297, 86–93.[CrossRef]
    [Google Scholar]
  29. Speck, P., Kline, K. A., Cheresh, P. & Longnecker, R. ( 1999; ). Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. J Gen Virol 80, 2193–2203.
    [Google Scholar]
  30. Stewart, S., Dawson, C. W., Takada, K., Curnow, J., Moody, C. A., Sixbey, J. W. & Young, L. S. ( 2004; ). Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. Proc Natl Acad Sci U S A 101, 15730–15735.[CrossRef]
    [Google Scholar]
  31. Swart, R., Ruf, I. K., Sample, J. & Longnecker, R. ( 2000; ). Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. J Virol 74, 10838–10845.[CrossRef]
    [Google Scholar]
  32. Takada, K. ( 1984; ). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33, 27–32.[CrossRef]
    [Google Scholar]
  33. Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A. & Ambinder, R. F. ( 1998; ). Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91, 1373–1381.
    [Google Scholar]
  34. Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A., Van Parijs, L., Jaenisch, R. & Jacks, T. ( 2004; ). Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci U S A 101, 10380–10385.[CrossRef]
    [Google Scholar]
  35. Young, L. S. & Murray, P. G. ( 2003; ). Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22, 5108–5121.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82790-0
Loading
/content/journal/jgv/10.1099/vir.0.82790-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error